img

Global Newcastle Disease Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Newcastle Disease Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
Newcastle Disease Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Newcastle Disease Vaccine market is projected to reach US$ 396.2 million in 2034, increasing from US$ 314.8 million in 2022, with the CAGR of 3.3% during the period of 2024 to 2034. Demand from Chicken and Duck & Goose are the major drivers for the industry.
Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology and Yebio, etc. are the leader of this industry. They got about 63% market shares. Asia-Pacific is the largest consumption place, with a consumption market share nearly 56%. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 2%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Newcastle Disease Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
DHN
Zoetis
ChengDu Tecbond
Elanco (Lohmann)
FATRO
CAVAC
Vaksindo
Segment by Type
Live Vaccines
Killed Vaccines

Segment by Application


Chicken
Duck & Goose
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Newcastle Disease Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Newcastle Disease Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Newcastle Disease Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Newcastle Disease Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Newcastle Disease Vaccine introduction, etc. Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Newcastle Disease Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Newcastle Disease Vaccine Market Overview
1.1 Newcastle Disease Vaccine Product Overview
1.2 Newcastle Disease Vaccine Market Segment by Type
1.2.1 Live Vaccines
1.2.2 Killed Vaccines
1.3 Global Newcastle Disease Vaccine Market Size by Type
1.3.1 Global Newcastle Disease Vaccine Market Size Overview by Type (2018-2034)
1.3.2 Global Newcastle Disease Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Newcastle Disease Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Newcastle Disease Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Newcastle Disease Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Newcastle Disease Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Newcastle Disease Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Newcastle Disease Vaccine Sales Breakdown by Type (2018-2024)
2 Global Newcastle Disease Vaccine Market Competition by Company
2.1 Global Top Players by Newcastle Disease Vaccine Sales (2018-2024)
2.2 Global Top Players by Newcastle Disease Vaccine Revenue (2018-2024)
2.3 Global Top Players by Newcastle Disease Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Newcastle Disease Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Newcastle Disease Vaccine Market Competitive Situation and Trends
2.5.1 Newcastle Disease Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Newcastle Disease Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Newcastle Disease Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Newcastle Disease Vaccine Market
2.8 Key Manufacturers Newcastle Disease Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Newcastle Disease Vaccine Status and Outlook by Region
3.1 Global Newcastle Disease Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Newcastle Disease Vaccine Historic Market Size by Region
3.2.1 Global Newcastle Disease Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Newcastle Disease Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Newcastle Disease Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Newcastle Disease Vaccine Forecasted Market Size by Region
3.3.1 Global Newcastle Disease Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Newcastle Disease Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Newcastle Disease Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Newcastle Disease Vaccine by Application
4.1 Newcastle Disease Vaccine Market Segment by Application
4.1.1 Chicken
4.1.2 Duck & Goose
4.1.3 Other
4.2 Global Newcastle Disease Vaccine Market Size by Application
4.2.1 Global Newcastle Disease Vaccine Market Size Overview by Application (2018-2034)
4.2.2 Global Newcastle Disease Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Newcastle Disease Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Newcastle Disease Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Newcastle Disease Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Newcastle Disease Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Newcastle Disease Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Newcastle Disease Vaccine Sales Breakdown by Application (2018-2024)
5 North America Newcastle Disease Vaccine by Country
5.1 North America Newcastle Disease Vaccine Historic Market Size by Country
5.1.1 North America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Newcastle Disease Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Newcastle Disease Vaccine Sales in Value by Country (2018-2024)
5.2 North America Newcastle Disease Vaccine Forecasted Market Size by Country
5.2.1 North America Newcastle Disease Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Newcastle Disease Vaccine Sales in Value by Country (2024-2034)
6 Europe Newcastle Disease Vaccine by Country
6.1 Europe Newcastle Disease Vaccine Historic Market Size by Country
6.1.1 Europe Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Newcastle Disease Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Newcastle Disease Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Newcastle Disease Vaccine Forecasted Market Size by Country
6.2.1 Europe Newcastle Disease Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Newcastle Disease Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Newcastle Disease Vaccine by Region
7.1 Asia-Pacific Newcastle Disease Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Newcastle Disease Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Newcastle Disease Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Newcastle Disease Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Newcastle Disease Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Newcastle Disease Vaccine Sales in Value by Region (2024-2034)
8 Latin America Newcastle Disease Vaccine by Country
8.1 Latin America Newcastle Disease Vaccine Historic Market Size by Country
8.1.1 Latin America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Newcastle Disease Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Newcastle Disease Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Newcastle Disease Vaccine Forecasted Market Size by Country
8.2.1 Latin America Newcastle Disease Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Newcastle Disease Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Newcastle Disease Vaccine by Country
9.1 Middle East and Africa Newcastle Disease Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Newcastle Disease Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Newcastle Disease Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Newcastle Disease Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Newcastle Disease Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Newcastle Disease Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merial
10.1.1 Merial Company Information
10.1.2 Merial Introduction and Business Overview
10.1.3 Merial Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merial Newcastle Disease Vaccine Products Offered
10.1.5 Merial Recent Development
10.2 CEVA
10.2.1 CEVA Company Information
10.2.2 CEVA Introduction and Business Overview
10.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 CEVA Newcastle Disease Vaccine Products Offered
10.2.5 CEVA Recent Development
10.3 QYH Biotech
10.3.1 QYH Biotech Company Information
10.3.2 QYH Biotech Introduction and Business Overview
10.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 QYH Biotech Newcastle Disease Vaccine Products Offered
10.3.5 QYH Biotech Recent Development
10.4 Ringpu Biology
10.4.1 Ringpu Biology Company Information
10.4.2 Ringpu Biology Introduction and Business Overview
10.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Ringpu Biology Newcastle Disease Vaccine Products Offered
10.4.5 Ringpu Biology Recent Development
10.5 Yebio
10.5.1 Yebio Company Information
10.5.2 Yebio Introduction and Business Overview
10.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Yebio Newcastle Disease Vaccine Products Offered
10.5.5 Yebio Recent Development
10.6 Harbin Veterinary Research Institute
10.6.1 Harbin Veterinary Research Institute Company Information
10.6.2 Harbin Veterinary Research Institute Introduction and Business Overview
10.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Products Offered
10.6.5 Harbin Veterinary Research Institute Recent Development
10.7 Merck Animal Health
10.7.1 Merck Animal Health Company Information
10.7.2 Merck Animal Health Introduction and Business Overview
10.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Merck Animal Health Newcastle Disease Vaccine Products Offered
10.7.5 Merck Animal Health Recent Development
10.8 DHN
10.8.1 DHN Company Information
10.8.2 DHN Introduction and Business Overview
10.8.3 DHN Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 DHN Newcastle Disease Vaccine Products Offered
10.8.5 DHN Recent Development
10.9 Zoetis
10.9.1 Zoetis Company Information
10.9.2 Zoetis Introduction and Business Overview
10.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Zoetis Newcastle Disease Vaccine Products Offered
10.9.5 Zoetis Recent Development
10.10 ChengDu Tecbond
10.10.1 ChengDu Tecbond Company Information
10.10.2 ChengDu Tecbond Introduction and Business Overview
10.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.10.4 ChengDu Tecbond Newcastle Disease Vaccine Products Offered
10.10.5 ChengDu Tecbond Recent Development
10.11 Elanco (Lohmann)
10.11.1 Elanco (Lohmann) Company Information
10.11.2 Elanco (Lohmann) Introduction and Business Overview
10.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Products Offered
10.11.5 Elanco (Lohmann) Recent Development
10.12 FATRO
10.12.1 FATRO Company Information
10.12.2 FATRO Introduction and Business Overview
10.12.3 FATRO Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.12.4 FATRO Newcastle Disease Vaccine Products Offered
10.12.5 FATRO Recent Development
10.13 CAVAC
10.13.1 CAVAC Company Information
10.13.2 CAVAC Introduction and Business Overview
10.13.3 CAVAC Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.13.4 CAVAC Newcastle Disease Vaccine Products Offered
10.13.5 CAVAC Recent Development
10.14 Vaksindo
10.14.1 Vaksindo Company Information
10.14.2 Vaksindo Introduction and Business Overview
10.14.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Vaksindo Newcastle Disease Vaccine Products Offered
10.14.5 Vaksindo Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Newcastle Disease Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Newcastle Disease Vaccine Industrial Chain Analysis
11.4 Newcastle Disease Vaccine Market Dynamics
11.4.1 Newcastle Disease Vaccine Industry Trends
11.4.2 Newcastle Disease Vaccine Market Drivers
11.4.3 Newcastle Disease Vaccine Market Challenges
11.4.4 Newcastle Disease Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Newcastle Disease Vaccine Distributors
12.3 Newcastle Disease Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Live Vaccines
Table 2. Major Company of Killed Vaccines
Table 3. Global Newcastle Disease Vaccine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Newcastle Disease Vaccine Sales by Type (2018-2024) & (M Doses)
Table 5. Global Newcastle Disease Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Newcastle Disease Vaccine Sales by Type (2018-2024) & (US& Million)
Table 7. Global Newcastle Disease Vaccine Market Share in Value by Type (2018-2024)
Table 8. Global Newcastle Disease Vaccine Price by Type (2018-2024) & (USD/K Doses)
Table 9. Global Newcastle Disease Vaccine Sales by Type (2024-2034) & (M Doses)
Table 10. Global Newcastle Disease Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Newcastle Disease Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Newcastle Disease Vaccine Sales Market Share in Value by Type (2024-2034)
Table 13. Global Newcastle Disease Vaccine Price by Type (2024-2034) & (USD/K Doses)
Table 14. North America Newcastle Disease Vaccine Sales by Type (2018-2024) & (M Doses)
Table 15. North America Newcastle Disease Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Newcastle Disease Vaccine Sales (M Doses) by Type (2018-2024)
Table 17. Europe Newcastle Disease Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Newcastle Disease Vaccine Sales (M Doses) by Type (2018-2024)
Table 19. Asia-Pacific Newcastle Disease Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Newcastle Disease Vaccine Sales (M Doses) by Type (2018-2024)
Table 21. Latin America Newcastle Disease Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Newcastle Disease Vaccine Sales (M Doses) by Type (2018-2024)
Table 23. Middle East and Africa Newcastle Disease Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Newcastle Disease Vaccine Sales by Company (2018-2024) & (M Doses)
Table 25. Global Newcastle Disease Vaccine Sales Share by Company (2018-2024)
Table 26. Global Newcastle Disease Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Newcastle Disease Vaccine Revenue Share by Company (2018-2024)
Table 28. Global Market Newcastle Disease Vaccine Price by Company (2018-2024) & (USD/K Doses)
Table 29. Global Newcastle Disease Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Newcastle Disease Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Newcastle Disease Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Newcastle Disease Vaccine Market
Table 33. Key Manufacturers Newcastle Disease Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Newcastle Disease Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Newcastle Disease Vaccine Sales by Region (2018-2024) & (M Doses)
Table 37. Global Newcastle Disease Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Newcastle Disease Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Newcastle Disease Vaccine Sales Market Share in Value by Region (2018-2024)
Table 40. Global Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 41. Global Newcastle Disease Vaccine Sales by Region (2024-2034) & (M Doses)
Table 42. Global Newcastle Disease Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Newcastle Disease Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Newcastle Disease Vaccine Sales Market Share in Value by Region (2024-2034)
Table 45. Global Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2024-2034)
Table 46. Global Newcastle Disease Vaccine Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Newcastle Disease Vaccine Sales by Application (2018-2024) & (M Doses)
Table 48. Global Newcastle Disease Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Newcastle Disease Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Newcastle Disease Vaccine Sales Market Share in Value by Application (2018-2024)
Table 51. Global Newcastle Disease Vaccine Price by Application (2018-2024) & (USD/K Doses)
Table 52. Global Newcastle Disease Vaccine Sales by Application (2024-2034) & (M Doses)
Table 53. Global Newcastle Disease Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Newcastle Disease Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Newcastle Disease Vaccine Sales Market Share in Value by Application (2024-2034)
Table 56. Global Newcastle Disease Vaccine Price by Application (2024-2034) & (USD/K Doses)
Table 57. North America Newcastle Disease Vaccine Sales by Application (2018-2024) (M Doses)
Table 58. North America Newcastle Disease Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Newcastle Disease Vaccine Sales by Application (2018-2024) (M Doses)
Table 60. Europe Newcastle Disease Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Newcastle Disease Vaccine Sales by Application (2018-2024) (M Doses)
Table 62. Asia-Pacific Newcastle Disease Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Newcastle Disease Vaccine Sales by Application (2018-2024) (M Doses)
Table 64. Latin America Newcastle Disease Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Newcastle Disease Vaccine Sales by Application (2018-2024) (M Doses)
Table 66. Middle East and Africa Newcastle Disease Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Newcastle Disease Vaccine Sales by Country (2018-2024) & (M Doses)
Table 68. North America Newcastle Disease Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Newcastle Disease Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Newcastle Disease Vaccine Sales Market Share in Value by Country (2018-2024)
Table 71. North America Newcastle Disease Vaccine Sales by Country (2024-2034) & (M Doses)
Table 72. North America Newcastle Disease Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Newcastle Disease Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Newcastle Disease Vaccine Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Newcastle Disease Vaccine Sales by Country (2018-2024) & (M Doses)
Table 76. Europe Newcastle Disease Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Newcastle Disease Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Newcastle Disease Vaccine Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Newcastle Disease Vaccine Sales by Country (2024-2034) & (M Doses)
Table 80. Europe Newcastle Disease Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Newcastle Disease Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Newcastle Disease Vaccine Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Newcastle Disease Vaccine Sales by Region (2018-2024) & (M Doses)
Table 84. Asia-Pacific Newcastle Disease Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Newcastle Disease Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Newcastle Disease Vaccine Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Newcastle Disease Vaccine Sales by Region (2024-2034) & (M Doses)
Table 88. Asia-Pacific Newcastle Disease Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Newcastle Disease Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Newcastle Disease Vaccine Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Newcastle Disease Vaccine Sales by Country (2018-2024) & (M Doses)
Table 92. Latin America Newcastle Disease Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Newcastle Disease Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Newcastle Disease Vaccine Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Newcastle Disease Vaccine Sales by Country (2024-2034) & (M Doses)
Table 96. Latin America Newcastle Disease Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Newcastle Disease Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Newcastle Disease Vaccine Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2018-2024) & (M Doses)
Table 100. Middle East and Africa Newcastle Disease Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Newcastle Disease Vaccine Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2024-2034) & (M Doses)
Table 104. Middle East and Africa Newcastle Disease Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Newcastle Disease Vaccine Sales Market Share in Value by Country (2024-2034)
Table 107. Merial Company Information
Table 108. Merial Introduction and Business Overview
Table 109. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 110. Merial Newcastle Disease Vaccine Product
Table 111. Merial Recent Development
Table 112. CEVA Company Information
Table 113. CEVA Introduction and Business Overview
Table 114. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 115. CEVA Newcastle Disease Vaccine Product
Table 116. CEVA Recent Development
Table 117. QYH Biotech Company Information
Table 118. QYH Biotech Introduction and Business Overview
Table 119. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 120. QYH Biotech Newcastle Disease Vaccine Product
Table 121. QYH Biotech Recent Development
Table 122. Ringpu Biology Company Information
Table 123. Ringpu Biology Introduction and Business Overview
Table 124. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 125. Ringpu Biology Newcastle Disease Vaccine Product
Table 126. Ringpu Biology Recent Development
Table 127. Yebio Company Information
Table 128. Yebio Introduction and Business Overview
Table 129. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 130. Yebio Newcastle Disease Vaccine Product
Table 131. Yebio Recent Development
Table 132. Harbin Veterinary Research Institute Company Information
Table 133. Harbin Veterinary Research Institute Introduction and Business Overview
Table 134. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 135. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product
Table 136. Harbin Veterinary Research Institute Recent Development
Table 137. Merck Animal Health Company Information
Table 138. Merck Animal Health Introduction and Business Overview
Table 139. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 140. Merck Animal Health Newcastle Disease Vaccine Product
Table 141. Merck Animal Health Recent Development
Table 142. DHN Company Information
Table 143. DHN Introduction and Business Overview
Table 144. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 145. DHN Newcastle Disease Vaccine Product
Table 146. DHN Recent Development
Table 147. Zoetis Company Information
Table 148. Zoetis Introduction and Business Overview
Table 149. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 150. Zoetis Newcastle Disease Vaccine Product
Table 151. Zoetis Recent Development
Table 152. ChengDu Tecbond Company Information
Table 153. ChengDu Tecbond Introduction and Business Overview
Table 154. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 155. ChengDu Tecbond Newcastle Disease Vaccine Product
Table 156. ChengDu Tecbond Recent Development
Table 157. Elanco (Lohmann) Company Information
Table 158. Elanco (Lohmann) Introduction and Business Overview
Table 159. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 160. Elanco (Lohmann) Newcastle Disease Vaccine Product
Table 161. Elanco (Lohmann) Recent Development
Table 162. FATRO Company Information
Table 163. FATRO Introduction and Business Overview
Table 164. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 165. FATRO Newcastle Disease Vaccine Product
Table 166. FATRO Recent Development
Table 167. CAVAC Company Information
Table 168. CAVAC Introduction and Business Overview
Table 169. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 170. CAVAC Newcastle Disease Vaccine Product
Table 171. CAVAC Recent Development
Table 172. Vaksindo Company Information
Table 173. Vaksindo Introduction and Business Overview
Table 174. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 175. Vaksindo Newcastle Disease Vaccine Product
Table 176. Vaksindo Recent Development
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Newcastle Disease Vaccine Market Trends
Table 180. Newcastle Disease Vaccine Market Drivers
Table 181. Newcastle Disease Vaccine Market Challenges
Table 182. Newcastle Disease Vaccine Market Restraints
Table 183. Newcastle Disease Vaccine Distributors List
Table 184. Newcastle Disease Vaccine Downstream Customers
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Newcastle Disease Vaccine Product Picture
Figure 2. Global Newcastle Disease Vaccine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Newcastle Disease Vaccine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Newcastle Disease Vaccine Sales Status and Outlook (2018-2034) & (M Doses)
Figure 5. Product Picture of Live Vaccines
Figure 6. Global Live Vaccines Sales YoY Growth (2018-2034) & (M Doses)
Figure 7. Product Picture of Killed Vaccines
Figure 8. Global Killed Vaccines Sales YoY Growth (2018-2034) & (M Doses)
Figure 9. Global Newcastle Disease Vaccine Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Newcastle Disease Vaccine Sales Market Share by Type in 2022 & 2034
Figure 11. North America Newcastle Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Newcastle Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Newcastle Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Newcastle Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Newcastle Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Newcastle Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Newcastle Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Newcastle Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Newcastle Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Newcastle Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Newcastle Disease Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Newcastle Disease Vaccine Revenue in 2022
Figure 23. Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Chicken
Figure 25. Global Chicken Sales YoY Growth (2018-2034) & (M Doses)
Figure 26. Product Picture of Duck & Goose
Figure 27. Global Duck & Goose Sales YoY Growth (2018-2034) & (M Doses)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2018-2034) & (M Doses)
Figure 30. Global Newcastle Disease Vaccine Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Newcastle Disease Vaccine Sales Market Share by Application in 2022 & 2034
Figure 32. North America Newcastle Disease Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. North America Newcastle Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Europe Newcastle Disease Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Europe Newcastle Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Newcastle Disease Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Newcastle Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Latin America Newcastle Disease Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Newcastle Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Newcastle Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Newcastle Disease Vaccine Manufacturing Cost Structure
Figure 43. Newcastle Disease Vaccine Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries